Back to HomeBeta

ICD-10 Coding for Prostatic Adenocarcinoma(C61, D07.5)

Complete ICD-10-CM coding and documentation guide for Prostatic Adenocarcinoma. Includes clinical validation requirements, documentation requirements, and coding pitfalls.

Also known as:

Prostate CancerAdenocarcinoma of the Prostate

Related ICD-10 Code Ranges

Complete code families applicable to Prostatic Adenocarcinoma

C61Primary Range

Malignant neoplasm of prostate

Primary code for prostatic adenocarcinoma, representing the malignant neoplasm of the prostate.

Carcinoma in situ of prostate

Used for high-grade prostatic intraepithelial neoplasia (PIN III) without invasion.

Personal history of malignant neoplasm of prostate

Used for patients with a history of treated prostate cancer.

Code Comparison: When to Use Each Code

Compare key differences between these codes to ensure accurate selection

CodeDescriptionWhen to UseKey Documentation
C61Malignant neoplasm of prostateUse when there is a confirmed diagnosis of adenocarcinoma of the prostate.
  • Histological confirmation of adenocarcinoma
  • Gleason score documentation
  • PSA levels
D07.5Carcinoma in situ of prostateUse for high-grade PIN without evidence of invasion.
  • Biopsy report indicating PIN III

Clinical Decision Support

Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.

Key Information: ICD-10 code for prostatic adenocarcinoma

Essential facts and insights about Prostatic Adenocarcinoma

The ICD-10 code for prostatic adenocarcinoma is C61, indicating a malignant neoplasm of the prostate.

Primary ICD-10-CM Codes for prostatic adenocarcinoma

Malignant neoplasm of prostate
Billable Code

Decision Criteria

clinical Criteria

  • Histological confirmation of adenocarcinoma

documentation Criteria

  • Gleason score and PSA levels must be documented

Applicable To

  • Adenocarcinoma of the prostate

Excludes

  • Benign prostatic hyperplasia (N40.0)

Clinical Validation Requirements

  • Histological confirmation of adenocarcinoma
  • Gleason score documentation
  • PSA levels

Code-Specific Risks

  • Confusion with benign conditions like BPH

Coding Notes

  • Ensure Gleason score and PSA levels are documented.

Ancillary Codes

Additional codes that should be used in conjunction with the main diagnosis codes when applicable.

Secondary malignant neoplasm of bone

C79.51
Use when there is evidence of bone metastases from prostate cancer.

Differential Codes

Alternative codes to consider when ruling out similar conditions to the primary diagnosis.

Benign prostatic hyperplasia

N40.0
Distinguished by lack of malignant histological findings.

Malignant neoplasm of prostate

C61
Invasive cancer confirmed by histology.

Documentation & Coding Risks

Avoid these common documentation and coding issues when documenting Prostatic Adenocarcinoma to ensure proper reimbursement, maintain compliance, and reduce audit risk. These guidelines are particularly important when using ICD-10 code C61.

Impact

Clinical: Inadequate treatment planning., Regulatory: Non-compliance with clinical guidelines., Financial: Potential claim denials.

Mitigation Strategy

Standardize pathology report templates, Educate clinicians on documentation requirements

Impact

Reimbursement: Incorrect coding can lead to denied claims., Compliance: Non-compliance with coding guidelines., Data Quality: Inaccurate clinical data reporting.

Mitigation Strategy

Clearly specify PIN grade in biopsy reports.

Impact

Lack of histological confirmation can lead to audit issues.

Mitigation Strategy

Ensure all diagnoses are supported by biopsy reports.

Documentation errors, coding pitfalls, and audit risks are interconnected aspects of medical coding and billing. Addressing all three areas helps ensure accurate coding, optimal reimbursement, and regulatory compliance.

Frequently Asked Questions

Common questions about ICD-10 coding for Prostatic Adenocarcinoma, with expert answers to help guide accurate code selection and documentation.

Documentation Templates for Prostatic Adenocarcinoma

Use these documentation templates to ensure complete and accurate documentation for Prostatic Adenocarcinoma. These templates include all required elements for proper coding and billing.

New diagnosis of prostatic adenocarcinoma

Specialty: Oncology

Required Elements

  • Histological type
  • Gleason score
  • PSA levels
  • Staging information

Example Documentation

Prostate biopsy confirms adenocarcinoma, Gleason 4+3=7, PSA 10.5 ng/mL.

Examples: Poor vs. Good Documentation

Poor Documentation Example
Prostate cancer diagnosed.
Good Documentation Example
Adenocarcinoma of the prostate, Gleason 4+3=7, PSA 10.5 ng/mL, stage T2b.
Explanation
The good example provides specific histological and clinical details necessary for accurate coding.

Need help with ICD-10 coding for Prostatic Adenocarcinoma? Ask your questions below.

Ask about any ICD-10 CM code, or paste a medical note

We build tools for
clinician happiness.

Learn More at Freed.ai
Back to HomeBeta

Built by Freed

Try Freed for free for 7 days.

Learn more